| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| —— | <i>sec</i>-butylium | 16548-59-7 | C4H9 |
| I型P21激活激酶(PAK)抑制剂(FRAX597) | FRAX597 | 1286739-19-2 | C29H28ClN7OS |
| I咪达那新杂质(N-(3氨基甲酰基3,3-DIPHENYLPROPYL)-OXAMIC酸) | N-(3-carbamoyl-3,3-diphenylpropyl)oxamic acid | 503598-07-0 | C18H18N2O4 |
| Ivacaftor苯磺酸盐 | N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide.besylate | 1134822-09-5 | C6H6O3S*C24H28N2O3 |
| Isoboonein; (4aR,6S,7R,7aS)-六氢-6-羟基-7-甲基环戊并[c]吡喃-3(1H)-酮 | isoboonein | 99946-04-0 | C9H14O3 |
| Isoboonein acetate; (4aR,6S,7R,7aS)-6-(乙酰氧基)六氢-7-甲基环戊并[c]吡喃-3(1H)-酮 | Isoboonein acetate | 99891-77-7 | C11H16O4 |
| Isobonducellin; (3Z)-2,3-二氢-7-羟基-3-[(4-甲氧基苯基)亚甲基]-4H-1-苯并吡喃-4-酮 | (Z)-7-hydroxy-3-(4'-methoxybenzylidene)chroman-4-one | 610778-85-3 | C17H14O4 |
| Ipragliflozin; (1S)-1,5-脱水-1-C-[3-[(1-苯并噻吩-2-基)甲基]-4-氟苯基]-D-葡糖醇 | ipragliflozin | 761423-87-4 | C21H21FO5S |
| Im-bzl-L-组氨酸甲酯 | N'-benzyl-L-histidine methyl ester | 19817-75-5 | C14H17N3O2 |
| Idasanutlin(4-((2R,3S,4R,5S)-3-(3-氯-2-氟苯基)-4-(4-氯-2-氟苯基)-4-氰基-5-新戊基吡咯烷-2-甲酰胺)-3-甲氧基苯甲酸;) | idasanutlin | 1229705-06-9 | C31H29Cl2F2N3O4 |
| IWP2;N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2d]嘧啶-2-基)硫基]乙酰胺 | N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide | 686770-61-6 | C22H18N4O2S3 |
| IU1抑制剂 | 1-[1-(4-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(pyrrolidin-1-yl)ethan-1-one | 314245-33-5 | C18H21FN2O |
| ITI214自由基 | (6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluoropyridin-2-yl)phenyl)methyl)cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one | 1160521-50-5 | C29H26FN7O |
| IS(+)-3-溴樟脑-10-磺酸 | ((1S,3S,4S)-3-bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate | 206860-46-0 | C10H17BrO5S |
| IRTK激活剂,负控制 | 3,6-dihydroxy-2-(4-methoxyphenyl)-5-phenyl-1,4-benzoquinone | 6172-50-5 | C19H14O5 |
| IRE1抑制剂(STF-083010) | N-[(2-hydroxy-1-naphthalenyl)methylene]-2-thiophenesulfonamide | 307543-71-1 | C15H11NO3S2 |
| IRAK抑制剂5;3-硝基-N-[1-(3-羟基丙基)-5-(2,2-二甲基丙酰基氧基)-1H-苯并咪唑-2-基]苯甲酰胺 | 1-(3-Hydroxypropyl)-2-[(3-Nitrobenzoyl)amino]-1h-Benzimidazol-5-Yl Pivalate | 509093-60-1 | C22H24N4O6 |
| IRAK-1-4 抑制剂 I | IRAK-1/4 Inhibitor | 509093-47-4 | C20H21N5O4 |
| IRAK 抑制剂 6; N-[2-甲氧基-4-(4-吗啉基)苯基]-2-(3-吡啶基)-4-噻唑甲酰 | IRAK inhibitor 6 | 1042672-97-8 | C20H20N4O3S |
| IR-797氯化物 | IR-797 chloride | —— | C31H34ClN2*Cl |
| IR-780 碘化物 | IR-780 | 207399-07-3 | C36H44ClN2*I |
| IR-775 氯化物 | IR-775 chloride | 199444-11-6 | C32H36ClN2*Cl |
| IR-1048四氟硼酸盐 | 1-(2,6-dimethylphenyl)-3-(3-propanol)thiourea | 120077-91-0 | C12H18N2OS |
| IPI145中间体-5 | 8-chloro-2-phenyl-3-((1S)-1-(9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one | 1350643-73-0 | C27H25ClN6O2 |
| IPI-926盐酸盐 | N-[(3R,3'R,3'aS,4aR,6'S,6aR,6bS,7'aR,9S,12aS,12bS)-3',6',11,12b-tetramethylspiro[1,2,3,4,4a,5,6,6a,6b,7,8,10,12,12a-tetradecahydronaphtho[2,1-a]azulene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridin-4-ium]-3-yl]methanesulfonamide;chloride | 1169829-40-6 | C29H48N2O3S*ClH |
| IPI-549,一种有效的选择性PI3KΓ抑制剂 | IPI-549 | 1693758-51-8 | C30H24N8O2 |
| IPDI二乙基己酯 | monoderm I-8 | 185568-15-4 | C28H54N2O4 |
| IPDI二丁基己酯 | Carbamic acid, (3-((((isodecyloxy)carbonyl)amino)methyl)-3,5,5-trimethylcyclohexyl)-, isodecyl ester | 185568-16-5 | C32H62N2O4 |
| IPAG(1-(4-碘苯基)-3-(2-金刚烷基)胍) | 1-(4-Iodophenyl)-3-(2-adamantyl)guanidine | 193527-91-2 | C17H22IN3 |
| IOTA-角叉菜 | [(2R,3S,4R,5R,6S)-6-[[(1R,3S,4R,5R,8S)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1R,3R,4R,5R,8S)-8-[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] sulfate | 11114-20-8 | C24H36O25S2-2 |
| INTEPIRDINE中间体 | 3-Bromo-8-chloroquinoline | 205111-94-0 | C9H5BrClN |
| INTEPIRDINE中间体 | tert-butyl 4-[3-(phenylsulfonyl)quinolin-8-yl]piperazine-1-carboxylate | 607743-10-2 | C24H27N3O4S |
| IN1861,1,2-双(5-(三甲基锡基)噻吩-2-基)乙炔 | 1,2-bis(5-(trimethylstannyl)thiophen-2-yl)ethyne | 1610057-24-3 | C16H22S2Sn2 |
| IN1771,(4,8-双(5-(2-乙基己基)-4-氟噻吩基)苯并[1,2-B:4,5-B']二噻吩基)双(三甲基锡基) | (4,8-bis(5-(2-ethylhexyl)-4-fluorothiophene-2-yl)benzo[1,2-b:4,5-b’]dithiophene-2,6-diyl)bis(trimethylstanne) | 1514905-25-9 | C40H56F2S4Sn2 |
| IN1579,(E)-2,3-二(5-溴噻吩-2-基)丙烯腈 | (E)-2,3-bis(5-bromothiophen-2-yl)acrylonitrile | 439588-79-1 | C11H5Br2NS2 |
| IN1538,4,6-双(4-癸基噻吩基)-噻吩并[3,4-C][1,2,5]噻二唑(S) | 5,7-bis(4-decanyl-2-thienyl)thieno[3,4-b]thiadiazole | 914613-38-0 | C32H46N2S4 |
| IN1537,7-溴-4,4,9,9-四己基-4,9-二氢-S-茚并[1,2-B:5,6-B']二噻吩-2-甲醛 | 7-bromo-4,9-dihydro-4,4,9,9-tetrahexyl-s-indaceno[1,2-b:5,6-b']dithiophene-2-carbaldehyde | 1509939-05-2 | C41H57BrOS2 |
| IN1273,5,5'-二溴-3,3'-双(2-(2-(2-甲氧基乙氧基)乙氧基)乙氧基)-2,2'-联噻吩 | 5,5'-dibromo-3,3'-bis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-2,2'-bithiophene | 1974310-58-1 | C22H32Br2O8S2 |
| IMEGLIMIN盐酸盐 | imeglimin hydrochloride | 352211-11-1 | C6H13N5*ClH |
| IM-017(9-[(R)-2-{9'-腺嘌呤基[R)-2-丙基)]}-磷酰甲氧基丙基]-腺嘌呤) | [[(2R)-1-(6-Amino-9H-purin-9-yl)propan-2-yloxy]methyl]phosphonic Acid Mono[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl] Ester | 1878175-77-9 | C17H23N10O4P |
| IKKε-IN-1抑制剂 | 5-[2-[(4-morpholinophenyl)amino]pyrimidin-4-yl]-2-tetrahydropyran-4-yloxy-benzonitrile | 1292310-49-6 | C26H27N5O3 |
| IKK-16,选择性IKK抑制剂 | IKK Inhibitor VII | 873225-46-8 | C28H29N5OS |
| II)二(4,4'-二吡唑基甲烷-N,N')-二(二氯铂 | 17β-<(1S)-1-Hydroxy-2-propynyl>androst-4-en-3-on | 72012-08-9 | C22H30O2 |
| IDH1突变体抑制剂(MUTANTIDH1-IN-1) | 2-(N-[2-(benzoimidazol-1-yl)ethanoyl]-3-fluoroanilino)-N-cyclohexyl-2-(2-methylphenyl)ethanamide | 1355326-21-4 | C30H31FN4O2 |
| ICI-199,441盐酸盐 | ICI 199441 hydrochloride | 115199-84-3 | C21H24Cl2N2O*ClH |
| ICARIIN衍生物 | 3,7-bis(2-hydroxyethyl)icaritin | 1067198-74-6 | C25H28O8 |
| IBERIOTOXIN毒素肽 | Iberiotoxin | 129203-60-7 | C179H274N50O55S7 |
| (i-丙基)-(2,2-二甲基-4-戊烯基)胺 | (i-propyl)-(2,2-dimethyl-4-pentenyl)amine | 1015419-66-5 | C10H21N |
| (i-丁氧基)二氯硼烷 | (i-butyloxy)dichloroborane | 89124-58-3 | C4H9BCl2O |
| (II)四(mu-乙酰)-二(1-甲基腺苷)二铑 | Fulicin | 137182-25-3 | C32H43N7O8 |